Fatima Laher to Human Immunodeficiency Virus Proteins
This is a "connection" page, showing publications Fatima Laher has written about Human Immunodeficiency Virus Proteins.
Connection Strength
0,703
-
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines. PLoS Med. 2020 02; 17(2):e1003038.
Score: 0,703